Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813878 · ClinicalTrials.gov registry record
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
A clinical trial, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- 126
- Enrollment target
NCT00813878 is a clinical trial that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 126 participants.
The verdict
NCT00813878 was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- 126 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures that measure biomarker levels in nipple section and blood samples, may help in the early detection of breast cancer. PURPOSE: This clinical trial is studying nipple secretion samples in detecting breast cancer in patients and healthy participants undergoing breast cancer screening, breast diagnostic studies, or treatment for benign breast disease.
Interventions
- GENETIC protein expression analysis
- GENETIC protein analysis
- OTHER immunohistochemistry staining method
- OTHER diagnostic laboratory biomarker analysis
- GENETIC proteomic profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2001-07 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813878
The ClinicalTrials.gov registry entry for NCT00813878 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which protein expression analysis is the first listed.
NCT00813878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813878 about?
NCT00813878 is a clinical study titled "Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease". RATIONALE: Diagnostic procedures that measure biomarker levels in nipple section and blood samples, may help in the early detection of breast cancer. PURPOSE: This clinical trial is studying nipple secretion samples in detecting breast cancer in patients and healthy participants undergoing breast c...
What is the current status of trial NCT00813878?
This trial is currently terminated. The enrollment target is 126 participants. The study started on 2001-07. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00813878?
The interventions under investigation include: protein expression analysis (GENETIC), protein analysis (GENETIC), immunohistochemistry staining method (OTHER), diagnostic laboratory biomarker analysis (OTHER), proteomic profiling (GENETIC).
Who is sponsoring clinical trial NCT00813878?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.